GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (NAS:ENLV) » Definitions » Inventories, Raw Materials & Components

Enlivex Therapeutics (Enlivex Therapeutics) Inventories, Raw Materials & Components : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Enlivex Therapeutics Inventories, Raw Materials & Components?

Enlivex Therapeutics's inventories, raw materials & components for the quarter that ended in Sep. 2023 was $0.00 Mil.


Enlivex Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Enlivex Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlivex Therapeutics Inventories, Raw Materials & Components Chart

Enlivex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Enlivex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Enlivex Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Enlivex Therapeutics (Enlivex Therapeutics) Business Description

Industry
Traded in Other Exchanges
Address
14 Einstein Street, Nes Ziona, ISR, 7403618
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Enlivex Therapeutics (Enlivex Therapeutics) Headlines

From GuruFocus

Enlivex Announces Upcoming May Conference Presentations

By GuruFocusNews GuruFocusNews 07-09-2022